510(k) Report

510(k) · Cleared

Cleared

Saige-Q

K203517510(k) TraditionalCleared Apr 16, 2021137-day reviewClass II21 CFR 892.2080

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

DeepHealth, Inc. · QFM Radiological Computer-Assisted Prioritization Software For Lesions

Cleared on Apr 16, 2021 as substantially equivalent to K183285 (Curemetrix, Inc., 2019) after a 137-day review. Its family tree reaches back 2 generations to 2018. 1 later device descends from it.

Decided
Apr 16, 2021
Review
137 days
Class
Class II
Product code
QFM
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN170073 (2018). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2026: 1 descendant clearedDEN170073 · ContaCT · Viz.Al, Inc. · 2018K183285 · cmTriage · Curemetrix, Inc. · 2019201620182020202220242026
Descendants, by generation 1 generation forward: 1 descendant K183285 · cmTriage · Curemetrix, Inc. · 2019DEN170073 · ContaCT · Viz.Al, Inc. · 20180
  1. Root · 2 generations backDEN170073 ContaCTViz.Al, Inc. · 2018
  2. 1 generation backK183285 cmTriageCuremetrix, Inc. · 2019
  3. This deviceK203517 Saige-QDeepHealth, Inc. · 2021
  4. Descendant · cites it directly · 0 of its ownK252954 MammoSightAINeurocareai, Inc. (Dba Savelife.Ai) · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K252954MammoSightAINeurocareai, Inc. (Dba Savelife.Ai) · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN170073ContaCTViz.Al, Inc.2018—
−1K183285cmTriageCuremetrix, Inc.2019—
0 (this device)K203517Saige-QDeepHealth, Inc.2021—
+1K252954MammoSightAINeurocareai, Inc. (Dba Savelife.Ai)2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K203517, 2018–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QFM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QFM device

  1. #1 K211733 Lunit INSIGHT CXR Triagescore 21.2 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K183285cmTriage
Summary page 4
…ological Computer-Assisted Triage and Notification Software Regulatory Class: Class II (21 CFR 892.2080) Product Code: QFM Predicate Devices CureMetrix, Inc., cmTriage, K183285 Device Description Saige-Q is a software workflow device that processes Digital Breast Tomosynthesis (DBT) and Ful…
Curemetrix, Inc.2019—

Also cleared against K183285: 3 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K252954MammoSightAINeurocareai, Inc. (Dba Savelife.Ai)20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 3 years and passes through 3 companies; a new generation was cleared every 2.1 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K252954 (Neurocareai, Inc. (Dba Savelife.Ai), 2026) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K183285.

How does its category compare?

All QFM devices

QFM Radiological Computer-Assisted Prioritization Software For Lesions: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · QFM

3in 2025

2019: 42020: 42021: 52022: 92023: 82024: 62025: 32026 (partial year): 2
2007high 9 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QFM

100in 2025

2019: 97 days median2020: 172 days median2021: 187 days median2022: 121 days median2023: 206 days median2024: 192 days median2025: 100 days median
2007high 206 (2023) · low 97 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QFM

No recall names QFM since 2007.

Adverse event reports per year · QFM

No MAUDE report names QFM since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
201949700
2020417200
2021518700
2022912100
2023820600
2024619200
2025310000
20262—0—

What is it indicated for?

Saige-Q is a software workflow tool designed to aid radiologists in prioritizing exams within the standard-of-care image worklist for compatible full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) screening mammograms. Saige-Q uses an artificial intelligence algorithm to generate a code for a given mammogram, indicative of the software’s suspicion that the mammogram contains at least one suspicious finding. Saige-Q makes the…

Read the full statement (155 words)

Saige-Q is a software workflow tool designed to aid radiologists in prioritizing exams within the standard-of-care image worklist for compatible full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) screening mammograms. Saige-Q uses an artificial intelligence algorithm to generate a code for a given mammogram, indicative of the software’s suspicion that the mammogram contains at least one suspicious finding. Saige-Q makes the assigned codes available to a PACS/EPR/RIS/workstation for worklist prioritization or triage.

Saige-Q is intended for passive notification only and does not provide any diagnostic information beyond triage and prioritization. Thus, it is not intended to replace the review of images or be used on a stand-alone basis for clinical decision-making. The decision to use Saige-Q codes and how to use those codes is ultimately up to the interpreting radiologist. The interpreting radiologist is responsible for reviewing each exam on a diagnostic viewer and evaluating each patient according to the current standard of care.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K203517: Saige-Q.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K203517

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026